Xenon Pharmaceuticals Inc

NASDAQ:XENE   3:59:52 PM EDT
17.94
-0.36 (-1.97%)
Products, Regulatory

Xenon Pharmaceuticals Announces Completion Of Patient Randomization In Xen1101 Phase 2B “X-Tole” Clinical Trial

Published: 07/07/2021 12:47 GMT
Xenon Pharmaceuticals Inc (XENE) - Xenon Pharmaceuticals Announces Completion of Patient Randomization in Xen1101 Phase 2b “x-tole” Clinical Trial and Announces Upcoming Investor Webinar With Leading Epilepsy Key Opinion Leaders.
Xenon Pharmaceuticals Inc - Anticipates Topline Results From Phase 2b X-tole Clinical Trial in Late September to Mid-october 2021.